PURDUE PHARMA, LP for PURDUE PHARMA LP
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances S.2839 - Comprehensive Addiction and Recovery Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| BURT E ROSEN | — |
Alcohol and Drug Abuse ALC
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances S.2839 - Comprehensive Addiction and Recovery Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| BURT E ROSEN | — |
Health Issues HCR
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances S.2839 - Comprehensive Addiction and Recovery Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| BURT E ROSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.